What is precision medicine? How can cancer patients benefit from it, and what role does it play in cellular therapy? In this episode our guests Dr Caroline Heckman (Research Director for Institute for Molecular Medicine at University of Helsinki) and Dr Kjetil Tasken (Director, OUH Centre for Precision Medicine in Cancer at Oslo University Hospital) explore the role of precision medicine in hematological cancers and explain how they have set up clinical trials to test the efficacy of precision medicine in both Norway and Finland.

In this episode we discuss the following articles:

1. Åslaug Helland et al, Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway, Journal of Translational Medicine, 2022.
2. Disha Malani et al,  Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia, Cancer Discovery, 2022.
3. Mariaserena Giliberto et al, Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically, Molecular Oncology, 2022.

You can follow Dr Kertil Tasken @KjetilTasken and Dr Caroline Heckman at @HeckmanLab on Twitter.